Baxter International Stock Jumps After Earnings Beat, But Novum Pump Risk Still Hangs Over 2026
Baxter International Inc. shares climbed Thursday, bouncing back after the company topped Wall Street’s first-quarter projections and stuck with its annual outlook. The medical products maker reported adjusted earnings of 36 cents a share on $2.70 billion in revenue, clearing LSEG’s bar of 31 cents and $2.62 billion. Product and margin worries had weighed on the stock prior to the results.
